THYMOSIN-1 5mg

Thymosin‑1 5 mg – Research Peptide Description

Thymosin‑1 (Tα1) is a synthetic peptide based on a naturally occurring thymic peptide, known for its immunomodulatory and tissue-protective properties. As a research peptide, Thymosin‑1 5 mg has been studied in preclinical models for its potential to modulate immune responses, enhance cellular repair, and support tissue regeneration. Its mechanism of action involves the regulation of immune signaling pathways, promotion of T-cell differentiation, and support of cryoprotective processes.

Key Research Focus Areas

Immune system modulation and T-cell studies
Tissue repair and regenerative research
Anti-inflammatory and cryoprotective pathway investigations
Preclinical models of infection and immune dysfunction
Cellular signaling and immunotherapy-related research

Compound Characteristics

Peptide Class: Synthetic research peptide
Sequence: 28-amino acid thymic-derived peptide
Dosage Form: 5 mg lyophilized peptide per vial
Research Use: Laboratory and scientific research only
Stability: Lyophilized for extended shelf life; reconstitute with sterile water or bacteriostatic water
Storage: Store in a cool, dry environment; protect from light

Important Notice
Thymosin‑1 5 mg is intended strictly for research purposes. It is not approved for human or veterinary use, consumption, diagnosis, or treatment of any medical condition.

This compound should be handled only by qualified professionals in controlled research environments, in accordance with all applicable laws, regulations, and laboratory safety protocols.